CJC with DAC 5 mg
Educational recon guide for a 5 mg CJC-1295 with DAC research vial and weekly unit mapping. Research use only.
Vial size
Same research phases — calculator defaults and unit math match the selected vial strength.
Vial
5 mg
Your BAC water
2 mL
Concentration
2.50 mg/mL
Per unit
~25.0 mcg
Frequency
1–2× weekly subcutaneous
Route
Subcutaneous
Live reconstitution calculator
Defaults match this guide (5 mg + 2 mL BAC). Change water or dose and the unit tables below update automatically.
Step 1
Reconstitution
Peptide amount in the vial and how much bacteriostatic water you add.
Step 2
Your dose
This guide uses microgram-scale research doses — quick picks are in mcg (100 mcg = 0.1 mg).
Quick select (mcg) — switch units or type any value
Suggested: 30-unit barrel (smallest that fits this draw).
Your draw
Results
Total draw
20 units
Volume
0.200 mL
Doses per vial
10
Syringes needed
1
Barrel
30-unit
Fits one syringe?
Yes
30-unit · 0.3 mL
Filled to 20 u
Fill one 30-unit U-100 syringe to about 20 units (0.200 mL).
Weekly research phases
Units and volumes recompute from your Step 1 concentration (2 mL BAC → 2.50 mg/mL · 25.0 mcg/unit).
Standard titration
With-DAC educational tables often cite roughly ~300 mcg–2 mg per injection, once or twice weekly. Less physiologic pulse shape than no-DAC + GHRP stacks; some communities prefer no-DAC for that reason.
| Phase | Weekly dose | Units | Volume |
|---|---|---|---|
| Weeks 1–4 | 500 mcg0.5 mg | 20 u | 0.20 mL500 mcg weekly — lower educational start |
| Weeks 5–8 | 1 mg1,000 mcg | 40 u | 0.40 mL1 mg weekly |
| Weeks 9+ | 2 mg2,000 mcg | 80 u | 0.80 mL2 mg weekly — upper common educational range (if vial allows) |
Advanced / higher-end
Faster escalation discussed in research communities — not a clinical recommendation
| Phase | Weekly dose | Units | Volume |
|---|---|---|---|
| Twice-weekly note · 1 mg × 2 | 1 mg1,000 mcg | 40 u | 0.40 mLSome write-ups split weekly exposure into two injections — count each draw in supplies |
Supplies planner
Using the guide’s phase ladder (500 mcg → 1 mg → 2 mg weekly (phase ladder)) over a 12-week schedule. Set a dose in Step 2 to plan supplies at your own amount.
Your recon
2 mL · 2.50 mg/mL
Dose in plan
Phase ladder
Syringe size
100-unit
Horizon
12-week schedule
CJC with DAC 5 mg vials
3 vials
~14 mg mg total peptide over this 12-week schedule at 500 mcg → 1 mg → 2 mg weekly (phase ladder). Each vial holds 5 mg.
Bacteriostatic water
2 × 3 mL or 1 × 10 mL
2 mL BAC per vial × 3 vials = 6.0 mL total. Buy as 2× 3 mL bottles or 1× 10 mL bottle (whichever you stock).
U-100 insulin syringes (100-unit)
12+ syringes
About one 100-unit syringe per injection for this schedule. Keep a few spares.
Alcohol swabs & sharps
~30 swabs · 1 sharps container
Wipe vial stopper and injection site each time. Dispose needles in a proper sharps container.
Reconstitution steps
- Allow the lyophilized 5 mg CJC-1295 with DAC vial and bacteriostatic water to reach room temperature.
- Draw 2.0 mL bacteriostatic water (default for this guide).
- Inject BAC slowly down the inner wall of the vial — avoid blasting the powder cake.
- Gently swirl or roll until the solution is clear. Do not shake hard (foaming).
- Label with recon date and concentration (e.g. "2.5 mg/mL — 2 mL BAC").
- Refrigerate at 2–8 °C (35–46 °F), protected from light. Prefer using a reconstituted multi-dose vial within ~28 days with sterile technique.
Storage
Lyophilized
Keep dry powder cold and dark when possible (−20 °C / −4 °F preferred for long-term research stock).
Reconstituted
Refrigerate at 2–8 °C (35–46 °F). Avoid freeze–thaw of the working solution. Prefer finishing within ~28 days.
- ·Write recon date and BAC volume on the label.
- ·Protect from light during storage.
- ·Discard if cloudy, particulates, or odd odor appear after reconstitution.
Protocol notes
- ·DAC extends half-life via albumin binding — schedule is not the same as no-DAC Mod GRF.
- ·See separate “CJC no DAC” guides for daily pulse-style recon math.
- ·Research use only.
Research context & considerations
CJC-1295 with Drug Affinity Complex was designed for prolonged GH/IGF-1 elevation. Research-market DAC vials are not approved drugs; long flat GH elevation has different risk discussions than brief pulses.
- ·Water retention and IGF-1 elevation are commonly discussed.
- ·Active malignancy and uncontrolled metabolic disease are high-caution contexts.
- ·Not FDA-approved.
- ·Pregnancy and pediatric use out of scope.
Catalog match
CJC1295 with DAC (CD5)
5mg x 10 vials · from $40